Egyptian Pharmaceuticals & Biotech Undervalued based on future growth

Results

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

2 companies

Egyptian International Pharmaceutical Industries

Market Cap: ج.م8.6b

Manufactures and sells pharmaceutical ampoules in Egypt and internationally.

PHAR

ج.م51.06

0.2%

33.0%

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)

Market Cap: ج.م6.8b

Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.

RMDA

ج.م4.53

0.4%

83.4%